Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
49.13
+0.50 (1.03%)
At close: Sep 28, 2026, 4:00 PM EDT
49.62
+0.49 (1.00%)
Pre-market: Sep 29, 2026, 7:35 AM EDT
Scholar Rock Holding Market Cap
Scholar Rock Holding has a market cap or net worth of $5.98 billion as of September 28, 2026. Its market cap has increased by 60.63% in one year.
Market Cap
5.98B
Enterprise Value
5.70B
1-Year Change
60.63%
Ranking
Category
Stock Price
$49.13
ChartMarket Cap Chart
Since May 24, 2018, Scholar Rock Holding's market cap has increased from $378.83M to $5.98B, an increase of 1,479.43%. That is a compound annual growth rate of 39.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 5.98B | 33.16% |
| Dec 31, 2025 | 4.49B | 11.06% |
| Dec 31, 2024 | 4.05B | 198.32% |
| Dec 29, 2023 | 1.36B | 190.08% |
| Dec 30, 2022 | 467.55M | -46.39% |
| Dec 31, 2021 | 872.09M | -46.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 6.79B |
| Belite Bio | 6.68B |
| Ligand Pharmaceuticals | 6.26B |
| CG Oncology | 6.17B |
| Travere Therapeutics | 5.80B |
| Mirum Pharmaceuticals | 5.71B |
| Kodiak Sciences | 5.64B |
| Oruka Therapeutics | 5.57B |